Get the Stockscreener App
8.98
1.97%
-0.18
Talis Biomedical Corp Stock (TLIS) Forecast
The Talis Biomedical Corp (TLIS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.7305, representing a -69.59% decrease from the current price of $8.98. The highest analyst price target is $5.0704, and the lowest is $0.3906.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TLIS Price Target
Average 4.1477
(-53.81% Downside)
Is Talis Biomedical Corp (TLIS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 50.85 | Neutral |
| STOCH(9,6) | 37.62 | Neutral |
| STOCHRSI(14) | 36.58 | Neutral |
| MACD(12,26) | 0.0762 | Sell |
| ADX(14) | 24.89 | Neutral |
| William %R | -62.61 | Neutral |
| CCI(14) | -60.42 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.088
Sell
|
9.0296
Sell
|
| MA20 |
9.0583
Sell
|
8.9895
Sell
|
| MA50 |
8.8179
Buy
|
8.7762
Buy
|
| MA100 |
8.4176
Buy
|
8.3131
Buy
|
| MA200 |
7.4356
Buy
|
6.9651
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, TLIS could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on TLIS, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 50.85 indicates that TLIS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 37.62 indicates that TLIS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 36.58 indicates that TLIS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.89 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -60.42 indicates that TLIS is still oversold but not to an extreme extent.
Long-term TLIS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Talis Biomedical Corp financial reports and earnings history, Talis Biomedical Corp (TLIS) stock could reach $17.34 by 2030, $52.05 by 2040 and $88.21 by 2050. See the projected annual prices until 2050 of the Talis Biomedical Corp stock below:
- Talis Biomedical Corp (TLIS) is expected to reach an average price of $9.1681 in 2035, with a high prediction of $10.17 and a low estimate of $9.4442. This indicates an $2.10% rise from the last recorded price of $8.98.
- Talis Biomedical Corp (TLIS) stock is projected to chart a bullish course in 2040, with an average price target of $52.24, representing an $481.73% surge from its current level. The forecast ranges from a conservative $52.21 to a sky-high $52.05.
- Our analysts predict Talis Biomedical Corp (TLIS) to jump 432.07% by 2045, soaring from $47.81 to an average price of $47.78, potentially reaching $48.42. While $47.81 is the low estimate, the potential upside is significant.
- Talis Biomedical Corp (TLIS) stock is expected to climb by 2050, reaching an average of $92.88, a $934.26% jump from its current level. However, a wide range of estimates exists, with high and low targets of $88.21 and $89.20, respectively, highlighting the market's uncertainty.
Talis Biomedical Corp Stock (TLIS) Year by Year Forecast
Talis Biomedical Corp Stock (TLIS) Price Forecast for 2024
Our forecast for TLIS stock price in 2024 now indicates an average price target of $7.3663 with a high forecast of $14.53 and a low forecast of $0.1977. The average prediction reflects an decrease of -17.97% from the last recorded price of $8.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $0.0456 | $0.3906 | $5.0704 | -99.49% |
| July, 2024 | $1.1689 | $0.2843 | $2.3971 | -86.98% |
| August, 2024 | $1.9135 | $2.7712 | $1.6699 | -78.69% |
| September, 2024 | $1.3982 | $1.8532 | $0.8195 | -84.43% |
| October, 2024 | $1.9214 | $2.2735 | $1.7241 | -78.60% |
| November, 2024 | $3.5261 | $2.7778 | $4.0474 | -60.73% |
| December, 2024 | $4.6907 | $3.9734 | $3.9007 | -47.77% |
Talis Biomedical Corp Stock (TLIS) Price Forecast for 2025
Talis Biomedical Corp Stock (TLIS) is expected to reach an average price of $7.1145 in 2025, with a high prediction of $9.1897 and a low estimate of $5.0394. This indicates an -20.77% fall from the last recorded price of $8.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.944 | $5.0394 | $5.694 | -33.81% |
| February, 2025 | $5.8586 | $6.2686 | $5.9713 | -34.76% |
| March, 2025 | $6.6932 | $6.9415 | $6.5332 | -25.46% |
| April, 2025 | $7.8365 | $7.1592 | $6.8306 | -12.73% |
| May, 2025 | $8.0312 | $7.9952 | $8.0112 | -10.57% |
| June, 2025 | $8.7058 | $8.6598 | $8.6258 | -3.05% |
| July, 2025 | $9.1891 | $8.734 | $8.8091 | +2.33% |
| August, 2025 | $9.1637 | $9.1164 | $9.0468 | +2.05% |
| September, 2025 | $9.2983 | $9.3083 | $9.1897 | +3.55% |
| October, 2025 | $9.0717 | $9.1116 | $9.1358 | +1.02% |
| November, 2025 | $9.0713 | $9.0953 | $9.0676 | +1.02% |
| December, 2025 | $8.9646 | $8.9623 | $8.9272 | -0.17% |
Talis Biomedical Corp Stock (TLIS) Price Forecast for 2026
The predicted value for Talis Biomedical Corp (TLIS) in 2026 is set at an average of $7.9558. Estimates vary from a peak of $8.8162 to a trough of $7.0954, indicating an -11.41% surge from the present price of $8.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $8.6342 | $8.6739 | $8.8162 | -3.85% |
| February, 2026 | $8.6688 | $8.5972 | $8.6128 | -3.47% |
| March, 2026 | $8.5414 | $8.5767 | $8.4861 | -4.88% |
| April, 2026 | $8.4789 | $8.4541 | $8.4821 | -5.58% |
| May, 2026 | $8.3014 | $8.3114 | $8.3848 | -7.56% |
| June, 2026 | $8.1659 | $8.215 | $8.2003 | -9.07% |
| July, 2026 | $7.8592 | $7.8693 | $7.9958 | -12.48% |
| August, 2026 | $7.7139 | $7.7256 | $7.768 | -14.10% |
| September, 2026 | $7.5972 | $7.6347 | $7.6286 | -15.40% |
| October, 2026 | $7.4318 | $7.4468 | $7.5459 | -17.24% |
| November, 2026 | $7.2365 | $7.2994 | $7.3358 | -19.42% |
| December, 2026 | $7.0612 | $7.0954 | $7.1951 | -21.37% |
Talis Biomedical Corp Stock (TLIS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Talis Biomedical Corp (TLIS) is $3.5111, with a high forecast of $7.0184 and a low forecast of $0.00389. This indicates an -60.90% decrease from the last price of $8.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0844 | $0.2657 | $7.0184 | -99.06% |
| February, 2027 | $0.381 | $0.00389 | $0.781 | -95.76% |
| March, 2027 | $0.8223 | $0.895 | $0.7223 | -90.84% |
| April, 2027 | $1.5069 | $1.1846 | $0.997 | -83.22% |
| May, 2027 | $1.9016 | $1.5156 | $1.8216 | -78.82% |
| June, 2027 | $1.1752 | $0.2838 | $1.2752 | -86.91% |
| July, 2027 | $1.9405 | $0.6592 | $2.2205 | -78.39% |
| August, 2027 | $1.8659 | $1.102 | $2.1932 | -79.22% |
| September, 2027 | $2.3926 | $1.0313 | $3.2523 | -73.36% |
| October, 2027 | $2.298 | $1.828 | $3.034 | -74.41% |
| November, 2027 | $2.7934 | $1.8493 | $3.6307 | -68.89% |
| December, 2027 | $3.1659 | $2.4731 | $3.8586 | -64.75% |
Talis Biomedical Corp Stock (TLIS) Price Forecast for 2028
In 2028, Talis Biomedical Corp (TLIS) is projected to reach an average price of $11.21, with a high projection of $18.10 and a low estimate of $4.31. This indicates an +24.78% rise from the last price of $8.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $10.46 | $4.31 | $8.7619 | +16.50% |
| February, 2028 | $13.01 | $10.66 | $12.91 | +44.89% |
| March, 2028 | $13.93 | $13.21 | $13.30 | +55.10% |
| April, 2028 | $14.51 | $15.45 | $14.30 | +61.55% |
| May, 2028 | $14.59 | $14.28 | $13.61 | +62.51% |
| June, 2028 | $14.14 | $14.49 | $14.03 | +57.49% |
| July, 2028 | $15.58 | $14.96 | $16.14 | +73.52% |
| August, 2028 | $16.66 | $15.95 | $16.18 | +85.51% |
| September, 2028 | $17.63 | $17.48 | $17.38 | +96.30% |
| October, 2028 | $17.38 | $17.79 | $17.57 | +93.51% |
| November, 2028 | $18.74 | $18.38 | $17.89 | +108.73% |
| December, 2028 | $18.98 | $18.39 | $18.10 | +111.39% |
Talis Biomedical Corp Stock (TLIS) Price Forecast for 2029
The 2029 price forecast for Talis Biomedical Corp Stock (TLIS) is $18.55 on average, with a high prediction of $19.57 and a low estimate of $17.53. This represents an +106.56% increase from the previous price of $8.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $19.42 | $19.10 | $18.99 | +116.25% |
| February, 2029 | $19.46 | $19.51 | $19.48 | +116.69% |
| March, 2029 | $19.80 | $19.73 | $19.47 | +120.47% |
| April, 2029 | $19.61 | $19.63 | $19.57 | +118.35% |
| May, 2029 | $19.47 | $19.50 | $19.51 | +116.86% |
| June, 2029 | $19.14 | $19.18 | $19.33 | +113.18% |
| July, 2029 | $18.98 | $19.00 | $19.05 | +111.33% |
| August, 2029 | $18.66 | $18.68 | $18.79 | +107.84% |
| September, 2029 | $18.17 | $18.21 | $18.47 | +102.32% |
| October, 2029 | $17.97 | $17.99 | $18.11 | +100.15% |
| November, 2029 | $17.67 | $17.71 | $17.77 | +96.75% |
| December, 2029 | $17.48 | $17.53 | $17.57 | +94.61% |
Talis Biomedical Corp Stock (TLIS) Price Forecast for 2030
Talis Biomedical Corp Stock (TLIS) is expected to reach an average price of $12.30 in 2030, with a high forecast of $17.34 and a low forecast of $7.2559. This signifies an +36.95% surge from the last price of $8.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $17.05 | $17.11 | $17.34 | +89.84% |
| February, 2030 | $16.67 | $16.75 | $16.91 | +85.67% |
| March, 2030 | $16.32 | $16.33 | $16.52 | +81.72% |
| April, 2030 | $16.01 | $16.02 | $16.19 | +78.26% |
| May, 2030 | $15.68 | $15.73 | $15.88 | +74.66% |
| June, 2030 | $15.35 | $15.37 | $15.59 | +70.98% |
| July, 2030 | $14.94 | $14.96 | $15.22 | +66.37% |
| August, 2030 | $14.61 | $14.65 | $14.85 | +62.71% |
| September, 2030 | $7.4687 | $7.6886 | $14.53 | -16.83% |
| October, 2030 | $7.9853 | $7.2559 | $7.0634 | -11.08% |
| November, 2030 | $7.8346 | $7.99 | $7.7346 | -12.76% |
| December, 2030 | $8.3538 | $8.1556 | $7.8439 | -6.97% |
0.75%
0.85%
Cap:
|
Volume (24h):